IMMUNEWALK
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Dec 2025)
What this means for you
This application is over — abandoned 29 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98252485
- Mark type
- Stylized text
- Filed
- 02 Nov 2023
- Published for opposition
- 01 Oct 2024
- Abandoned
- 29 Dec 2025
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, Inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseases and disorders, chronic inflammatory disease, and cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseases and disorders, chronic inflammatory disease, and cancer; Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for regulating immune response; Nutritional and dietary supplements for immune system support
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical, biopharmaceutical, and biotechnology fields; research and development of pharmaceutical preparations and medicines; medical and scientific research services; pharmaceutical and biopharmaceutical product evaluation; consulting in the field of pharmaceutical, biopharmaceutical, and biotechnology research; testing of pharmaceuticals; scientific laboratory services and medical research laboratory services.
Owner
- ImmuneWalk Therapeutics Inc., Pearl River, NY, US
- ImmuneWalk Therapeutics Inc., Pearl River, NY, US
Prosecution history
- 29 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Oct 2025 — ASSIGNED TO EXAMINER
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2025 — SOU EXTENSION 1 GRANTED
- 02 May 2025 — SOU EXTENSION 1 FILED
- 02 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 26 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 26 Aug 2024 — EXAMINERS AMENDMENT E-MAILED